2022年05月13日，德琪医药口服XPO1抑制剂希维奥®（塞利尼索片）正式面向中国多家医院、互联网医院及DTP药房供药。
希维奥（塞利尼索），前称ATG-010，在中国获批用于联合低剂量地塞米松治疗受过至少四种既往治疗且对至少两种蛋白酶体抑制剂、两种免疫调节剂及一种抗CD38单克隆抗体药物存在难治的复发/难治性多发性骨髓瘤（R/R MM）患者。
- 希维奥(塞利尼索) 规格为20mg*12片/盒， 发售价为：¥22435元/盒。
- 希维奥(塞利尼索) 规格为20mg*16片/盒， 发售价为：¥29600元/盒。
![开售|希维奥(塞利尼索)[¥22435元/起]](https://www.100pei.com/wp-content/uploads/2022/05/100pei.com_2022-05-19_02-46-55.jpg "开售|希维奥(塞利尼索)[¥22435元/起]")
扫一扫 
![开售|捷帕力(匹妥布替尼)[¥36960元/盒]](https://www.100pei.com/wp-content/themes/100pei/timthumb.php?src=https://www.100pei.com/wp-content/uploads/2025/02/100pei.com_2025-02-19_11-05-45.jpeg&h=250&w=384&zc=1)
![开售|艾心安(瑞卡西单抗)[¥1660元/盒]](https://www.100pei.com/wp-content/themes/100pei/timthumb.php?src=https://www.100pei.com/wp-content/uploads/2025/01/100pei.com_2025-01-22_11-33-12.jpg&h=250&w=384&zc=1)
![开售|奥凯乐(瑞普替尼)[¥5894元/盒]](https://www.100pei.com/wp-content/themes/100pei/timthumb.php?src=https://www.100pei.com/wp-content/uploads/2025/01/100pei.com_2025-01-21_08-34-09.jpg&h=250&w=384&zc=1)
![开售|柏瑞素(口服紫杉醇溶液)[¥4980元/盒]](https://www.100pei.com/wp-content/themes/100pei/timthumb.php?src=https://www.100pei.com/wp-content/uploads/2025/01/100pei.com_2025-01-16_13-11-24.png&h=250&w=384&zc=1)
